Treating COVID-19: As widely-available steroid dexamethasone raises hopes, a look at other potential treatments in trials already
So far there are no approved treatments for the coronavirus infection which has claimed more than 443,000 lives globally and 9,900 in India alone
COVID-19 'RECOVERY' Trial: Dexamethasone found life-saving in seriously-ill patients in preliminary tests
As part of the Recovery trial, a range of potential treatments is being tested in consenting COVID-19 patients admitted to NHS hospitals in the UK.
Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19
HCQ has demonstrated in-vitro activity against SARS-CoV-2 and shown to be clinically beneficial in several small single-centre studies with significant limitations.
Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks
It is a promising solution at the present gloomy situation, but till we have reliable evidence on utility unregulated use is to be avoided
Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial
California-based biotech company Gilead Sciences and the US government reported that in a major study, remdesivir shortened the time it takes for COVID-19 patients to recover by four days on average
Several antiviral drugs to treat the coronavirus outbreak under clinical trials, shown good efficacy: Chinese official
Hospitals are using plasma from recovered patients, that is rich in protective antibodies, to treat severely affected patients.